阴道切开路径对Ⅰa2~Ⅱa2期子宫颈癌腹腔镜根治性子宫切除术后预后及复发部位的影响
回顾性分析965例Ⅰa2~Ⅱa2期子宫颈癌腹腔镜根治性子宫切除术患者,中位随访62个月,比较经阴道与经腹腔镜两种阴道切开路径的预后及复发部位。临床分期、淋巴结转移、阴道切缘阳性、宫体浸润为独立预后危险因素;两种路径的5年DFS和OS无显著差异,但经阴道组腹腔复发率显著低于经腹腔镜组。
要点
- 临床分期、淋巴结转移、阴道切缘阳性、宫体浸润是影响预后的独立危险因素。
- 经阴道与经腹腔镜切开路径的5年DFS和OS无显著差异。
- 经阴道组腹腔复发率显著低于经腹腔镜组,仅见于无淋巴结转移或无宫体浸润患者。
核心结论
- 临床分期、淋巴结转移、阴道切缘阳性和宫体浸润是显著影响Ⅰa2~Ⅱa2期子宫颈癌患者预后的独立危险因素。
- 对于无淋巴结转移、无宫体浸润的患者,经阴道切开路径虽可降低术后腹腔复发率,但不足以改善5年DFS和OS。
研究设计与样本
- 回顾性收集2015年1月至2018年12月于陆军军医大学第一附属医院接受腹腔镜根治性子宫切除术的965例Ⅰa2~Ⅱa2期子宫颈癌患者临床病理资料。
- 中位年龄47.0岁,中位随访62个月(48~74个月),按阴道切开路径分为经阴道组475例和经腹腔镜组490例。
主要发现
- 随访期内复发137例(14.2%,137/965),死亡98例(10.2%,98/965),5年DFS和OS分别为85.8%和89.9%。
- 多因素分析显示,临床分期(HR=1.882,95%CI 1.305~2.716)、淋巴结转移状态(HR=2.178,95%CI 1.483~3.200)、宫体浸润状态(HR=3.650,95%CI 1.906~6.988)是5年DFS的独立影响因素(P均<0.001)。
- 多因素分析显示,临床分期(HR=2.500,95%CI 1.580~3.956)、淋巴结转移状态(HR=2.053,95%CI 1.309~3.218)、宫体浸润状态(HR=3.984,95%CI 1.917~8.280)、阴道切缘状态(HR=3.235,95%CI 1.021~10.244)是5年OS的独立影响因素(P均<0.05)。
- 经阴道组与经腹腔镜组5年DFS分别为85.9%和85.6%(P=0.794),5年OS分别为90.8%和89.3%(P=0.966),差异均无统计学意义。
- 经阴道组腹腔复发率显著低于经腹腔镜组[0.6%(3/468) vs 2.3%(11/485),P=0.037];盆腔复发率、残端复发率、淋巴结及远处转移率、总复发转移率两组比较差异均无统计学意义(P均>0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the factors affecting the prognosis of stage Ⅰa2-Ⅱa2 cervical cancer after laparoscopic radical hysterectomy (LRH), and to compare the prognosis and recurrence sites of patients with different colpotomy paths. Methods: The clinical data of 965 patients with stage Ⅰa2-Ⅱa2 cervical cancer who underwent LRH in the First Affiliated Hospital of Army Medical University from January 2015 to December 2018 were collected. The median age was 47.0 years of all patients with a median follow-up of 62 months (48-74 months). Cox regression was used to perform the univariate and multivariate analysis of the clinicopathological factors associated with the prognosis that included disease-free survival (DFS) and overall survival (OS). Patients were categorized into LRH through vaginal colpotomy (VC group, n=475) and LRH through intracorporeal colpotomy (IC group, n=490) according to the colpotomic approaches. The prognosis and recurrence sites of patients in each group were compared. Results: (1) During the follow-up period, 137 cases recurred (14.2%, 137/965) and 98 cases died (10.2%, 98/965). The 5-year DFS and OS were 85.8% and 89.9%, respectively. In univariate analysis, positive vaginal margin (PVM) was significantly affected the 5-year OS of patients with cervical cancer (P=0.023), while clinical stage, maximum diameter of tumor, degree of pathological differentiation, lymph node metastasis (LNM), depth of cervical stromal invasion, parametrium involvement, and uterine corpus invasion (UCI) were significantly associated with 5-year DFS and OS in patients with cervical cancer (all P<0.05). In multivariate analysis, clinical stage (HR=1.882, 95%CI: 1.305-2.716), LNM (HR=2.178, 95%CI: 1.483-3.200) and UCI (HR=3.650, 95%CI: 1.906-6.988) were independent risk factors of 5-year DFS (all P<0.001). Clinical stage (HR=2.500, 95%CI: 1.580-3.956), LNM (HR=2.053, 95%CI: 1.309-3.218), UCI (HR=3.984, 95%CI: 1.917-8.280), PVM (HR=3.235, 95%CI: 1.021-10.244) were independent risk factors of 5-year OS (all P<0.05). (2) Different colpotomy paths did not significantly affect the 5-year DFS and OS of patients with stage Ⅰa2-Ⅱa2 cervical cancer. The 5-year DFS in VC group and IC group were 85.9% and 85.6% (P=0.794), and the 5-year OS were 90.8% and 89.3% (P=0.966), respectively. Recurrence patterns consisted of intraperitoneal recurrence, pelvic recurrence, vaginal stump recurrence, and lymph node and distant metastasis. The intraperitoneal recurrence rate of VC group was significantly lower than that of IC group [0.6%(3/468) vs 2.3% (11/485), P=0.037], while the rates of pelvic recurrence, vaginal stump recurrence, lymph node and distant metastasis and overall recurrence were not significantly different between two groups (all P>0.05). Subgroup analysis of patients with different clinical stages, LNM and UCI showed that statistical differences of the intraperitoneal recurrence rates between two groups were only in patients without LNM (0.5% vs 2.3%, P=0.030) or without UCI (0.7% vs 2.3%, P=0.037). Conclusions: Clinical stage, LNM, PVM and UCI are independent risk factors for the prognosis of patients with stage Ⅰa2-Ⅱa2 cervical cancer. For patients without LNM or UCI, LRH through VC could reduce the intraperitoneal recurrence rate, while it is not enough to improve 5-year DFS and OS of patients. Low proportion of intraperitoneal recurrence, intra-operative tumor cells spillage to vagina stump and pelvic cavity might be the explanation. 目的: 探究影响Ⅰa2~Ⅱa2期子宫颈癌腹腔镜根治性手术患者预后的相关因素,并比较不同阴道切开路径患者的预后及复发转移部位的差异。 方法: 收集2015年1月至2018年12月于陆军军医大学第一附属医院接受腹腔镜根治性手术的965例Ⅰa2~Ⅱa2期子宫颈癌患者的临床病理资料,患者的中位年龄为47.0岁,所有患者均随访,中位随访时间为62个月(48~74个月)。采用Cox比例风险模型对可能影响子宫颈癌患者预后[包括无复发生存率(DFS)和总生存率(OS)]的临床病理因素进行单因素分析和多因素分析。阴道切开路径分为两种:关闭气腹后经阴道钳夹子宫颈并下拉后切开阴道穹隆(经阴道组,475例),在腹腔镜气腹条件下经腹切开阴道穹隆(经腹腔镜组,490例);进一步对不同阴道切开路径子宫颈癌患者的预后及复发转移部位进行比较。 结果: (1)965例子宫颈癌患者中,随访期内复发137例(14.2%,137/965),死亡98例(10.2%,98/965);患者的5年DFS和OS分别为85.8%和89.9%。单因素分析显示,临床分期、肿瘤最大径、病理分化程度、淋巴结转移状态、肌层浸润深度、宫旁浸润、宫体浸润均是显著影响子宫颈癌患者5年DFS和OS的因素(P均<0.05),阴道切缘状态是显著影响子宫颈癌患者5年OS的因素(P=0.023)。多因素分析显示,临床分期(HR=1.882,95%CI为1.305~2.716)、淋巴结转移状态(HR=2.178,95%CI为1.483~3.200)、宫体浸润状态(HR=3.650,95%CI为1.906~6.988)均是显著影响Ⅰa2~Ⅱa2期子宫颈癌患者5年DFS的独立因素(P均<0.001);临床分期(HR=2.500,95%CI为1.580~3.956)、淋巴结转移状态(HR=2.053,95%CI为1.309~3.218)、宫体浸润状态(HR=3.984,95%CI为1.917~8.280)、阴道切缘状态(HR=3.235,95%CI为1.021~10.244)均是显著影响Ⅰa2~Ⅱa2期子宫颈癌患者5年OS的独立因素(P均<0.05)。(2)不同阴道切开路径不影响Ⅰa2~Ⅱa2期子宫颈癌患者的5年DFS和OS,经阴道组和经腹腔镜组患者的5年DFS分别为85.9%和85.6%,5年OS分别为90.8%和89.3%,两组分别比较,差异均无统计学意义(P=0.794、P=0.966)。子宫颈癌患者的复发转移部位包括腹腔复发、盆腔复发、残端复发、淋巴结及远处转移,经阴道组患者的腹腔复发率显著低于经腹腔镜组[分别为0.6%(3/468)、2.3%(11/485);P=0.037];而两组患者的盆腔复发率、残端复发率、淋巴结及远处转移率、总复发转移率分别比较,差异均无统计学意义(P均>0.05)。进一步对不同临床分期、有无淋巴结转移和有无宫体浸润的子宫颈癌患者进行亚组(即分别分为经阴道组和经腹腔镜组)分析,结果显示,仅在无淋巴结转移(分别为0.5%、2.3%;P=0.030)、无宫体浸润(分别为0.7%、2.3%;P=0.037)患者中,两组患者的腹腔复发率比较均有显著差异。 结论: 临床分期、淋巴结转移、阴道切缘阳性和宫体浸润是显著影响Ⅰa2~Ⅱa2期子宫颈癌患者预后的独立危险因素。对于无淋巴结转移、无宫体浸润的患者,经阴道切开路径虽可以降低术后的腹腔复发率,但不足以改善术后的5年DFS和OS,这可能与腹腔复发患者比例低以及由于阴道未封闭导致肿瘤的阴道和盆腔暴露有关。.
引用
- Zhou D, Li YD, Ling KJ, et al. [Effects of colpotomic approaches on prognosis and recurrence sites of stage Ⅰa2-Ⅱa2 cervical cancer after laparoscopic radical hysterectomy]. Zhonghua Fu Chan Ke Za Zhi. 2023. PMID: 36720615. doi:10.3760/cma.j.cn112141-20221022-00647
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。